Invasive Candidiasis
📧 Sign up to get email alerts when something new happens for Invasive Candidiasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug [Phase 1]
A Phase 1 study evaluating the safety and drug blood levels of micafungin (Mycamine) in infants and toddlers with invasive candidiasis, esop…
-
CLINICAL_TRIALS trial_result · 2014-07-23Clinical Trial Update: Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections
Clinical trial update describing outcomes of patients with severe Candida albicans infections who did not respond to fluconazole treatment.
-
FDA approval · 2014-03-28FDA Approved: ERAXIS — Supplemental Application (Roerig)
FDA's supplemental application for ERAXIS (anidulafungin) submitted by Roerig is noted as a supplemental approval action. The entry shows th…
-
FDA approval · 2013-12-18FDA Approved: CANCIDAS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for CANCIDAS (caspofungin acetate) from Merck Sharp & Dohme LLC to update its labeling.
-
FDA approval · 2013-11-25FDA Approved: NOXAFIL — Original Application (Merck Sharp & Dohme LLC)
FDA approves NOXAFIL (posaconazole) through Merck's original NDA. The approval recognizes posaconazole for prevention and treatment of invas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067) [Phase 2]
A Phase 2 pilot feasibility trial of MK-0991 in patients at high risk for invasive candidiasis in a critical care setting; the study was ter…
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients [NA]
This completed trial compared beta-D-glucan–guided surveillance with preemptive anidulafungin versus standard care in surgical ICU patients …
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Effect of Weight and/or Obesity on Caspofungin Drug Concentrations [Phase 4]
Phase 4 study assessing how weight and obesity influence caspofungin drug concentrations; results were posted in 2013.
-
FDA approval · 2013-01-08FDA Approved: CANCIDAS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for CANCIDAS (caspofungin acetate) from Merck Sharp & Dohme LLC, authorizing changes to the drug's l…
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System [Phase 3]
A Phase 3 trial comparing anidulafungin to caspofungin for serious Candida infections in immunocompromised patients was terminated; results …
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) [Phase 3]
Phase 3 trial results for caspofungin acetate (MK0991) in Chinese adults with esophageal candidiasis or invasive candidiasis were completed …
-
CLINICAL_TRIALS research · 2012-04-06Clinical Trial Update: Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU)
A clinical trial update describing the pharmacokinetics of anidulafungin in ICU patients, including those with invasive candidiasis.
-
FDA approval · 2012-01-30FDA Approved: FLUCONAZOLE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s generic fluconazole under Original Application (ANDA 078698). The approval covers multiple fun…
-
CLINICAL_TRIALS research · 2011-12-01Clinical Trial Update: Role of Polymorphisms in the Dectin-1 Gene in Determining the Risk of Candida Colonization and Infection in Critically Ill Patients
The document reports a clinical trial exploring whether polymorphisms in the Dectin-1 gene influence the risk of Candida colonization and in…
-
FDA approval · 2011-10-13FDA Approved: FLUCONAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for fluconazole by Rising Pharma Holdings, Inc., authorizing an updated generic product under the AN…
-
CLINICAL_TRIALS trial_result · 2011-10-03Clinical Trial Update: Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis [Phase 4]
Pfizer completed a Phase 4 trial evaluating the safety and efficacy of anidulafungin (Eraxis) in patients with candidemia or invasive candid…
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Anidulafungin Pharmacokinetics in Intensive Care Unit Patients
The document provides an update on the pharmacokinetics of anidulafungin in intensive care unit patients with invasive candidiasis or candid…
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED) [Phase 3]
A Phase 3 study evaluating caspofungin (MK0991) in Japanese patients with invasive Candida or invasive Aspergillus infections has completed,…
-
FDA approval · 2011-06-08FDA Approved: MYCAMINE — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for MYCAMINE (micafungin sodium) from Astellas Pharma US, Inc., updating its labeling with indicatio…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study [Phase 3]
Phase 3 trial of anidulafungin for candidemia and invasive candidiasis in intensive care patients completed. Results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) [Phase 4]
Phase 4 randomized trial evaluating caspofungin prophylaxis followed by pre-emptive therapy for invasive candidiasis in ICU patients; the st…
-
CLINICAL_TRIALS research · 2011-04-25Clinical Trial Update: The Relationship Between Morphology and Virulent Genes of Candida Albicans and Clinical Aspects, Surveillance of Fungemia
An ongoing clinical trial update examining how Candida albicans morphology and virulence genes relate to clinical outcomes in candidemia and…
-
CLINICAL_TRIALS trial_result · 2011-01-17Clinical Trial Update: This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis [Phase 4]
Phase 4 open-label, non-comparative trial assessing a short course of IV anidulafungin, with optional oral voriconazole, for candidemia and …
-
CLINICAL_TRIALS research · 2010-12-06Clinical Trial Update: A Multicenter Observational Study of Invasive Candida Infections Among ICU Patients in China
This clinical trial update describes a multicenter observational study of invasive candidiasis in ICU patients in China. The current status …
-
FDA approval · 2009-05-04FDA Approved: CANCIDAS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Cancidas (caspofungin acetate) to expand its labeling.